Distúrbio metabólico caracterizado pela deficiência de lipoproteína de alta densidade (alfa) no sangue.
Introdução
O que você precisa saber de cara
Distúrbio metabólico caracterizado pela deficiência de lipoproteína de alta densidade (alfa) no sangue.
Tem tratamento?
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 22 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 54 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
2 genes identificados com associação a esta condição.
Central enzyme in the extracellular metabolism of plasma lipoproteins. Synthesized mainly in the liver and secreted into plasma where it converts cholesterol and phosphatidylcholines (lecithins) to cholesteryl esters and lysophosphatidylcholines on the surface of high and low density lipoproteins (HDLs and LDLs) (PubMed:10329423, PubMed:19065001, PubMed:26195816). The cholesterol ester is then transported back to the liver. Has a preference for plasma 16:0-18:2 or 18:O-18:2 phosphatidylcholines
Secreted
Lecithin-cholesterol acyltransferase deficiency
A disorder of lipoprotein metabolism characterized by inadequate esterification of plasmatic cholesterol. Two clinical forms are recognized: complete LCAT deficiency and fish-eye disease. LCATD is generally referred to the complete form which is associated with absence of both alpha and beta LCAT activities resulting in esterification anomalies involving both HDL (alpha-LCAT activity) and LDL (beta-LCAT activity). It causes a typical triad of diffuse corneal opacities, target cell hemolytic anemia, and proteinuria with renal failure.
Catalyzes the translocation of specific phospholipids from the cytoplasmic to the extracellular/lumenal leaflet of membrane coupled to the hydrolysis of ATP (PubMed:24097981, PubMed:35974019). Thereby, participates in phospholipid transfer to apolipoproteins to form nascent high density lipoproteins/HDLs (PubMed:14754908). Transports preferentially phosphatidylcholine over phosphatidylserine (PubMed:24097981). May play a similar role in the efflux of intracellular cholesterol to apolipoproteins
Cell membraneEndosome
Tangier disease
An autosomal recessive disorder characterized by near absence of plasma high density lipoproteins, low serum HDL cholesterol, and massive tissue deposition of cholesterol esters. Clinical features include large yellow-orange tonsils, hepatomegaly, splenomegaly, enlarged lymph nodes, and often sensory polyneuropathy.
Medicamentos e terapias
Mecanismo: Histamine H1 receptor antagonist
Mecanismo: Voltage-gated L-type calcium channel blocker
Mecanismo: Histamine H1 receptor antagonist
Mecanismo: Histamine H1 receptor antagonist
Mecanismo: Beta-1 adrenergic receptor antagonist
Mecanismo: Voltage-gated L-type calcium channel blocker
Mecanismo: Potassium-transporting ATPase inhibitor
Mecanismo: Angiotensin-converting enzyme inhibitor
Mecanismo: Serotonin 2a (5-HT2a) receptor antagonist
Mecanismo: Potassium-transporting ATPase inhibitor
Variantes genéticas (ClinVar)
275 variantes patogênicas registradas no ClinVar.
Classificação de variantes (ClinVar)
Distribuição de 353 variantes classificadas pelo ClinVar.
Vias biológicas (Reactome)
5 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Hipoalfalipoproteinemia
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
Pesquisa e ensaios clínicos
78 ensaios clínicos encontrados.
Publicações mais relevantes
Exercise training for the management of dyslipidaemia. A position statement from Exercise and Sports Science Australia (ESSA).
This position stand will aim to summarise the effect of different lipid markers on cardiovascular disease (CVD) progression; determine the exercise prescription (ExRx) to optimise favourable lipid profile changes; ascertain if an optimal exercise prescription exists for different types of dyslipidaemias; and provide recommendations for ExRx for dyslipidaemia. Synthesis of published literature on exercise training and lipid profiles. Total cholesterol (TC), high density lipoprotein (HDL-C), low density lipoprotein (LDL-C), triglycerides (TG) and very low density lipoprotein (VLDL-C) respond favourably to exercise training, but the effect sizes are moderate compared to lipid lowering medication (LLM). Apolipoproteins respond favourably to exercise training, but less evidence currently exists. A combination (CT) of aerobic (AT) and resistance (RT) training is optimal to improve lipid profile. For dyslipidaemia and hyperlipidaemia, one should consider greater emphasis on AT, whilst for hypoalphalipoproteinemia RT may be prioritised. Lipid changes observed with exercise are modest but offer a valuable complement to dietary therapy and may delay onset or reduce initial dose of dyslipidaemia medication in people treated for primary CVD prevention. Each extra week of exercise training appears to induce a -0.5 mg/dl reduction in TC. Session time, exercise intensity and frequency should be increased in this order for programme progression. Lipids and apolipoproteins respond favourably to exercise training and the effect size is moderate. Both AT and CT improved all lipids, only HDL was improved with RT, so CT appears optimal. It appears that greater exercise programme volume, defined primarily by longer session (minutes) and programme (weeks) times, and hence cardiorespiratory fitness, seems to lead to further improvements in lipid profile.
Association between indoor air pollution exposure and dyslipidemia among Chinese adults: The role of leisure-time physical activity.
Dyslipidemia, a major factor for cardiovascular diseases, has been linked to air pollution exposure. However, evidence on the association between indoor air pollution (IAP) from solid fuel use and dyslipidemia remains limited, as does the potential mitigating role of leisure-time physical activity (LTPA). This cross-sectional study analyzed data from 69,680 adults in the China Multi-Ethnic Cohort (CMEC). IAP exposure was assessed based on self-reported solid fuel use for cooking and heating. Dyslipidemia was defined using blood lipid measurements. LTPA was quantified in metabolic equivalent task-hours per week (MET-h/week). Multivariable logistic regression and interaction analyses were conducted to evaluate associations and synergistic effects. Each 10 MET-h/day increase in LTPA was associated with a 9 % reduction in the prevalence of high non-HDL-C (OR = 0.91, 95 % CI: 0.84-0.98) and a 13 % reduction in hypertriglyceridemia (OR = 0.87, 95 % CI: 0.82-0.92). Solid fuel use for cooking was significantly associated with an increased prevalence of hypertriglyceridemia (OR = 1.14, 95 % CI: 1.09-1.20) and hyperbetalipoproteinemia (OR = 1.20, 95 % CI: 1.13-1.28), while, solid fuel use for heating was linked to higher prevalence of hypertriglyceridemia (OR = 1.34, 95 % CI: 1.27-1.42) and hypoalphalipoproteinemia (OR = 1.13, 95 % CI: 1.05-1.21). LTPA attenuated these associations, with significant multiplicative and additive-scale interactions observed (e.g., for heating fuel use and LTPA on dyslipidemia: P-interaction < 0.05, RERI = 0.18, 95 % CI: 0.08-0.27). Participants using solid fuels and engaging in low LTPA had the highest prevalence of dyslipidemia. Moreover, subgroup analyses confirmed stronger adverse effects of IAP in low-LTPA individuals. Household solid fuel use is associated with dyslipidemia, particularly hypertriglyceridemia and hyperbetalipoproteinemia. LTPA may mitigate these associations, highlighting the dual importance of clean energy adoption and physical activity (PA) promotion in reducing dyslipidemia burden. Public health strategies should target high- populations, such as rural communities with limited access to clean fuels.
Global prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis.
Global regional variations in dyslipidemia prevalence underscore the need for an updated global overview of the magnitude of dyslipidemia over time. To estimate the global prevalence of dyslipidemia in adults, considering scientific evidence published in the last 20 years, while analyzing associated sociodemographic and geographic factors. A systematic review and meta-analysis were conducted following PRISMA guidelines. The bibliographic search was performed in PubMed, SCOPUS, Web of Science, and EMBASE, including observational studies published between 2000 and 2025 that reported the prevalence of dyslipidemia components in general adult populations, including hypertriglyceridemia, hypercholesterolemia, hypoalphalipoproteinemia or low high-density lipoprotein cholesterol (HDL-C) levels (< 40 mg/dL for men and < 50 mg/dL for women), and elevated low-density lipoprotein cholesterol (LDL-C). Statistical analyses included meta-analysis with random effects models, stratified analyses by sex and country, and meta-regression by publication year. A total of 206 studies were included, primarily cross-sectional (98.5%). The global prevalence was 28.8% for hypertriglyceridemia, 24.1% for hypercholesterolemia, 38.4% for low HDL-C, and 18.93% for high LDL-C. Men presented a higher prevalence of hypertriglyceridemia (33.8% vs. 24.5% in women), while women showed a higher frequency of low HDL-C (40.5% vs. 34.1% in men). The highest prevalences of low HDL-C and mixed dyslipidemia patterns were observed in the Middle East and Latin America. Temporal trends revealed a progressive increase in hypertriglyceridemia and low HDL-C, with a decrease in hypercholesterolemia and high LDL-C. There is an epidemiological transition in the dyslipidemia profile, from classic hypercholesterolemia toward a predominance of hypertriglyceridemia and low HDL-C, with important differences by sex and region. These findings significantly affect cardiovascular prevention and health policies addressing residual risk beyond LDL-C control.
Metabolic Syndrome Prevalence and Its Components in Adolescents from Western Mexico.
To evaluate the predictive risk factors associated with the prevalence of metabolic syndrome (MetS) in adolescents from the western region of Mexico. An analytical cross-sectional study was conducted with a sample of 516 adolescents. Anthropometric data, blood pressure, and biochemical determinations were obtained. The diagnosis of MetS was based on the criteria proposed by de Ferranti in 2004. The triglyceride-glucose index (TyG index) was calculated, where a value >4.68 indicates insulin resistance (IR). Risk factors associated with MetS were evaluated using a logistic regression model. The statistical analysis was performed with the level of statistical significance established was p < 0.05. The MetS prevalence was 17.2% among adolescents. One out of every two adolescents with obesity presented with MetS. Abdominal obesity and dyslipidemia are the most common components. Predictors of MetS included male sex, early adolescence, waist-to-height ratio (WHtR) > 0.5, increased body fat percentage, and TyG Index > 4.68 (IR). In the sex-specific analysis, a WHtR > 0.5 and IR were associated with MetS in female adolescents. In male adolescents, IR and body fat percentage were associated with MetS. The WHtR was associated with IR, and hypertriglyceridemia was associated with elevated alanine aminotransferase. In this study, two out of ten adolescents presented with MetS. In boys, a high prevalence of abdominal obesity, hypoalphalipoproteinemia, insulin resistance and MetS was observed. The risk of developing MetS is greater in preadolescent boys with abdominal obesity, high levels of body fat, and a TyG index > 4.68.
Changes in physical activity before and after the diagnosis of dyslipidemia and the risk of atrial fibrillation: a population-based study in South Korea.
While physical activity is known to influence atrial fibrillation risk in the general population, evidence is limited among patients newly diagnosed with dyslipidemia. This study aimed to evaluate the association between changes in physical activity before and after dyslipidemia diagnosis and atrial fibrillation risk. Using the Korean National Health Insurance Service database, we identified 441,509 Korean adults newly diagnosed with dyslipidemia between 2011 and 2015, free of atrial fibrillation at baseline and with complete data. Metabolic equivalent tasks (METs)-min/week were calculated before and after dyslipidemia diagnosis. Participants were followed up until atrial fibrillation, death, or December 31, 2021. During 3,164,996 person-years of follow-up, 6003 patients developed atrial fibrillation. Increasing physical activity from inactive to ≥1000 MET-min/week was associated with reduced atrial fibrillation risk (adjusted hazard ratio [aHR], 0.85; 95 % confidence interval [CI], 0.81-0.90), compared with inactive. Conversely, decreasing physical activity from ≥1000 MET-min/week to inactive was associated with increased atrial fibrillation risk (aHR, 1.23; 95 % CI, 1.15-1.31). These results were consistent regardless of statin use, hypoalphalipoproteinemia, and hyperlipidemia status. Encouraging newly diagnosed dyslipidemia patients to increase their physical activity levels may help reduce their risk of atrial fibrillation.
Publicações recentes
How urban park exposure shapes dyslipidemia risk: Evidence from mobility data in Seoul, South Korea.
Exercise training for the management of dyslipidaemia. A position statement from Exercise and Sports Science Australia (ESSA).
Association between indoor air pollution exposure and dyslipidemia among Chinese adults: The role of leisure-time physical activity.
Global prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis.
Metabolic Syndrome Prevalence and Its Components in Adolescents from Western Mexico.
📚 EuropePMC104 artigos no totalmostrando 96
Exercise training for the management of dyslipidaemia. A position statement from Exercise and Sports Science Australia (ESSA).
Journal of science and medicine in sportAssociation between indoor air pollution exposure and dyslipidemia among Chinese adults: The role of leisure-time physical activity.
Ecotoxicology and environmental safetyGlobal prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis.
Journal of health, population, and nutritionMetabolic Syndrome Prevalence and Its Components in Adolescents from Western Mexico.
Pediatric reportsChanges in physical activity before and after the diagnosis of dyslipidemia and the risk of atrial fibrillation: a population-based study in South Korea.
Preventive medicine reportsThe overlooked role of high-density lipoprotein in adrenal stress adaptation: the HDL/SCARB1 axis as a regulator of stress-induced steroidogenesis.
Current opinion in endocrinology, diabetes, and obesityResidential Greenness and the Incidence of Dyslipidemia in Chinese Adults: A Large Prospective Cohort Study.
Environment & health (Washington, D.C.)Spectrum and Correlates of Dyslipidemia in People Living with HIV on Dolutegravir-Based Regimen Attending Kabutare Hospital, Southern Rwanda: A Cross-Sectional Study.
HIV/AIDS (Auckland, N.Z.)Sex differences in the prevalence and profile of metabolic syndrome: results of a screening program from Western Mexico in self-appointed healthy adults.
Endokrynologia PolskaThe nonlinear association between temperature anomaly and serum lipid profiles: A nationwide longitudinal panel study.
Environmental researchCardiometabolic Risk in Chronic Spinal Cord Injury: A Systematic Review with Meta-Analysis and Temporal and Geographical Trends.
Journal of clinical medicineDeciphering the association of cholesteryl ester transfer protein (CETP) gene polymorphisms with high-density lipoprotein cholesterol (HDL-c) levels in the Bangladeshi population.
Biochemistry and biophysics reportsA Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular Disease.
NutrientsA novel variant in the ABCA1 gene for Tangier Disease with diffuse histiocytosis of bone marrow.
Journal of clinical lipidologyPositive correlation between n- 6 : n- 3 PUFA ratio intake with serum oxHDL/HDL-c ratio in patients with coronary artery disease.
Coronary artery diseasePrimary Hypoalphalipoproteinemia With Significant Premature Atherosclerosis.
JACC. Case reportsGlycemic Control and Cardiometabolic Risk in Black Zimbabweans with Type 2 Diabetes Mellitus.
Diabetes, metabolic syndrome and obesity : targets and therapyLongitudinal analysis of clinical and laboratory biomarkers in a patient with familial lecithin: cholesterol acyltransferase deficiency (FLD) and accelerated eGFR decline: A case study.
Journal of clinical lipidologyImprovement of metabolic syndrome and its components in patients who underwent transsphenoidal resection for pituitary adenoma.
Acta neurochirurgicaInterleukin 6 polymorphisms are associated with cardiovascular risk factors in premature coronary artery disease patients and healthy controls of the GEA Mexican study.
Experimental and molecular pathologyA decreased level of high-density lipoprotein is a possible risk factor for type 2 diabetes mellitus: A review.
Health science reportsMicroarray analysis identifies human apoA-IMilano and apoA-II as determinants of the liver gene expression related to lipid and energy metabolism.
Experimental cell researchIncreased carotid intima-media thickness and cardiometabolic risk factors are associated with IL-6 gene polymorphisms in Mexican individuals: The Genetics of Atherosclerotic Disease Mexican study.
Biomolecules & biomedicineA machine learning approach to personalized predictors of dyslipidemia: a cohort study.
Frontiers in public healthRare primary dyslipidaemias associated with low LDL and HDL cholesterol values in Portugal.
Frontiers in geneticsPrevalencia de glucosa alterada en ayuno y dislipidemia entre pacientes mexicanos con VIH naïve a tratamiento antirretroviral.
Cirugia y cirujanosInteraction between SIDT2 and ABCA1 Variants with Nutrients on HDL-c Levels in Mexican Adults.
NutrientsVery low HDL levels: clinical assessment and management.
Archives of endocrinology and metabolism[An abnormal lipid profile: when to perform additional research for a genetic cause?].
Nederlands tijdschrift voor geneeskundeBiochemical, Clinical, and Genetic Characteristics of Mexican Patients with Primary Hypertriglyceridemia, Including the First Case of Hyperchylomicronemia Syndrome Due to GPIHBP1 Deficiency.
International journal of molecular sciencesAssociation of Urinary Zinc Concentrations with Dyslipidemia and Its Subtypes: Baseline Data from the Chinese Multi-Ethnic Cohort (CMEC) Study.
Biological trace element researchDifferential distribution of gene polymorphisms associated with hypercholesterolemia, hypertriglyceridemia, and hypoalphalipoproteinemia among Native American and Mestizo Mexicans.
World journal of hepatologyAssociation of the rs17574 DPP4 Polymorphism with Premature Coronary Artery Disease in Diabetic Patients: Results from the Cohort of the GEA Mexican Study.
Diagnostics (Basel, Switzerland)Associations of typical antibiotic residues with elderly blood lipids and dyslipidemia in West Anhui, China.
Ecotoxicology and environmental safetyWhole-exome sequencing reveals damaging gene variants associated with hypoalphalipoproteinemia.
Journal of lipid researchBeneficial effects of fish and fish peptides on main metabolic syndrome associated risk factors: Diabetes, obesity and lipemia.
Critical reviews in food science and nutritionFood Consumption and Metabolic Risks in Young University Students.
International journal of environmental research and public healthLipid and Lipoprotein Profile in HIV-Infected and Non-Infected Diabetic Patients: A Comparative Cross-Sectional Study Design, Southwest Ethiopia.
HIV/AIDS (Auckland, N.Z.)Identification of the RORα Transcriptional Network Contributes to the Search for Therapeutic Targets in Atherosclerosis.
Biological & pharmaceutical bulletinEffect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study.
Pharmacology research & perspectivesThe rs12617336 and rs17574 Dipeptidyl Peptidase-4 Polymorphisms Are Associated With Hypoalphalipoproteinemia and Dipeptidyl Peptidase-4 Serum Levels: A Case-Control Study of the Genetics of Atherosclerotic Disease (GEA) Cohort.
Frontiers in geneticsInterferon Regulatory Factor 5 (IRF5) Gene Haplotypes Are Associated with Premature Coronary Artery Disease. Association of the IRF5 Polymorphisms with Cardiometabolic Parameters. The Genetics of Atherosclerotic Disease (GEA) Mexican Study.
BiomoleculesCardiometabolic Factors in Pediatric Patients with Chronic Diseases.
Archives of medical researchPolygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance.
Current opinion in lipidologyNo benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels.
AtherosclerosisEpstein-Barr virus-induced gene 3 (EBI3) single nucleotide polymorphisms and their association with central obesity and risk factors for cardiovascular disease: The GEA study.
CytokineRare Diseases Related with Lipoprotein Metabolism.
Advances in experimental medicine and biologyAssociations between residential greenness and blood lipids in Chinese Uyghur adults.
Environment internationalDyslipidemia prevalence, awareness, treatment and control in Mexico: results of the Ensanut 2012.
Salud publica de MexicoIs long-term PM1 exposure associated with blood lipids and dyslipidemias in a Chinese rural population?
Environment internationalLIPA gene mutations affect the composition of lipoproteins: Enrichment in ACAT-derived cholesteryl esters.
AtherosclerosisR230C but not - 565C/T variant of the ABCA1 gene is associated with type 2 diabetes in Mexicans through an effect on lowering HDL-cholesterol levels.
Journal of endocrinological investigationLong-term effects of ambient air pollutants to blood lipids and dyslipidemias in a Chinese rural population.
Environmental pollution (Barking, Essex : 1987)Epidemiology and prevalence of hyperuricemia among men and women in Chinese rural population: The Henan Rural Cohort Study.
Modern rheumatologyIs Hyperuricemia, an Early-Onset Metabolic Disorder, Causally Associated with Cardiovascular Disease Events in Han Chinese?
Journal of clinical medicineThe rs2066808 Polymorphism Located Near the IL-23A Gene Is Associated with Premature Coronary Artery Disease in Mexican Population (GEA Study).
DNA and cell biologyIdentification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
Lipids in health and diseaseSelective Correction of Genotype Yield by Probucol in HDL-Deficient Mice Propagation.
Journal of atherosclerosis and thrombosisParaoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage.
AtherosclerosisHIV disease, metabolic dysfunction and atherosclerosis: A three year prospective study.
PloS oneAssociation between chronic hepatitis B infection and metabolic syndrome.
Journal of diabetes and metabolic disordersProgress in finding pathogenic DNA copy number variations in dyslipidemia.
Current opinion in lipidologyRaet1e Polymorphisms Are Associated with Increased Risk of Developing Premature Coronary Artery Disease and with Some Cardiometabolic Parameters: The GEA Mexican Study.
Mediators of inflammationRelation of High-Density Lipoprotein Charge Heterogeneity, Cholesterol Efflux Capacity, and the Expression of High-Density Lipoprotein-Related Genes in Mononuclear Cells to the HDL-Cholesterol Level.
LipidsIdentification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1.
Journal of clinical lipidologyHypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease.
Arteriosclerosis, thrombosis, and vascular biologyHigh density lipoprotein cholesterol and cancer: Marker or causative?
Progress in lipid researchLarge-scale deletions of the ABCA1 gene in patients with hypoalphalipoproteinemia.
Journal of lipid researchA novel homozygous ABCA1 variant in an asymptomatic man with profound hypoalphalipoproteinemia.
Journal of clinical lipidologyHepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in Mice: Role of Scavenger Receptor Class B Type I/ATP-Binding Cassette Transporter A1-Dependent Pathways.
Arteriosclerosis, thrombosis, and vascular biology[Association of leptin with cardiometabolic factors in schoolchildren and adolescents with congenital adrenal hyperplasia].
Gaceta medica de MexicoLipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development.
Frontiers in neurologyAssociation between cardiorespiratory fitness and metabolic risk factors in a population with mild to severe obesity.
BMC obesityATP-binding cassette transporter A1: A promising therapy target for prostate cancer.
Molecular and clinical oncologyThe association between serum 25-hydroxyvitamin D3 concentration and serum lipids in the rural population of China.
Lipids in health and diseaseStructural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels.
Biochimica et biophysica acta. Molecular basis of diseaseHeritability, parental transmission and environment correlation of pediatric-onset type 2 diabetes mellitus and metabolic syndrome-related traits.
Diabetes research and clinical practiceAssociation of ATP-Binding Cassette Transporter A1 (ABCA1)-565 C/T Gene Polymorphism with Hypoalphalipoproteinemia and Serum Lipids, IL-6 and CRP Levels.
Avicenna journal of medical biotechnologyNutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome.
World journal of diabetesA Novel Mutation in ABCA1 Gene Causing Tangier Disease in an Italian Family with Uncommon Neurological Presentation.
Frontiers in neurologySmall HDL subclasses become cholesterol-poor during postprandial period after a fat diet intake in subjects with high triglyceridemia increases.
Clinica chimica acta; international journal of clinical chemistryAssociation of apolipoprotein E polymorphism with plasma lipid disorders, independent of obesity-related traits in Vietnamese children.
Lipids in health and diseaseA randomized, placebo-controlled, double-blind study on the effects of (-)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects.
International journal of cardiologyAges at Onset of 5 Cardiometabolic Diseases Adjusting for Nonsusceptibility: Implications for the Pathogenesis of Metabolic Syndrome.
American journal of epidemiology[Clinical Application of Methods for the Qualitative Evaluation of Lipid Abnormalities].
Rinsho byori. The Japanese journal of clinical pathologyDIAGNOSTIC PERFORMANCE OF WAIST CIRCUMFERENCE MEASUREMENTS FOR PREDICTING CARDIOMETABOLIC RISK IN MEXICAN CHILDREN.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical EndocrinologistsGene-based therapies in lipidology: current status and future challenges.
Current opinion in lipidologyTargeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.
Molecular & cellular proteomics : MCP[Nicotinic acid increases cellular transport of high density lipoprotein cholesterol in patients with hypoalphalipoproteinemia].
Revista medica de ChileEarly coronary artery disease--Usual and unusual suspects.
International journal of cardiologyDose-related antihyperglycemic and hypolipidemic effects of two novel thiazolidin-4-ones in a rodent model of metabolic syndrome.
Journal of diabetesInflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes.
Journal of diabetes researchBeta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice.
Vascular pharmacologyTherapeutic ultrasound: Increased HDL-Cholesterol following infusions of acoustic microspheres and apolipoprotein A-I plasmids.
AtherosclerosisEffect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA.
Journal of lipid researchHepatic lipase (LIPC) C-514T gene polymorphism is associated with cardiometabolic parameters and cardiovascular risk factors but not with fatty liver in Mexican population.
Experimental and molecular pathologyAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Hipoalfalipoproteinemia.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Hipoalfalipoproteinemia
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Exercise training for the management of dyslipidaemia. A position statement from Exercise and Sports Science Australia (ESSA).
- Association between indoor air pollution exposure and dyslipidemia among Chinese adults: The role of leisure-time physical activity.
- Global prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis.
- Metabolic Syndrome Prevalence and Its Components in Adolescents from Western Mexico.
- Changes in physical activity before and after the diagnosis of dyslipidemia and the risk of atrial fibrillation: a population-based study in South Korea.
- How urban park exposure shapes dyslipidemia risk: Evidence from mobility data in Seoul, South Korea.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:31153(Orphanet)
- MONDO:0017773(MONDO)
- GARD:18801(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Q5959167(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar